Botulinum Toxin Therapy for Psychiatric Disorders in Clinical Practice: A Retrospective Case Study

Inhibiting the facial expression of negative emotions via botulinum toxin A (BTX) has been shown to mitigate symptoms of clinical depression in randomized controlled trials. This retrospective case study sought to reproduce the beneficial effects of BTX in a naturalistic setting for major depressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehnert, Franziska, Neumann, Insa, Krüger, Tillmann H. C., Wollmer, Marc A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301237/
https://www.ncbi.nlm.nih.gov/pubmed/37368686
http://dx.doi.org/10.3390/toxins15060385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301237/
https://www.ncbi.nlm.nih.gov/pubmed/37368686
http://dx.doi.org/10.3390/toxins15060385

Ejemplares similares